![]() ProKidney ProKidney is a biotechnology company that specializes in chronic disease treatment solutions. | Sanesco Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | ![]() ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | ![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | |
Founding Date | Founding Date N/A | Founding Date 2004 | Founding Date 2004 | Founding Date 2010 | Founding Date 2011 |
Type | Type Public | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations HQ | Locations Arden, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Cambridge, US HQ | Locations Seattle, US HQ |
Employees | Employees N/A | Employees 23 | Employees 73 | Employees 2 | Employees 27 |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $6.1m (FY, 2022) |
Net income | Net income N/A | Net income N/A | Net income ($102.1m) (FY, 2025) | Net income N/A | Net income ($187.9m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 56.2m | Total funding raised $ 72.8m | Total funding raised $ 171m |
Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health.
View company
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company